{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:51:23Z","timestamp":1776153083149,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s12020-021-02857-0","type":"journal-article","created":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T04:02:21Z","timestamp":1631937741000},"page":"244-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A long noncoding RNA\u2013microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas"],"prefix":"10.1007","volume":"75","author":[{"given":"Suman","family":"Ghosal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boqun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh-Truc","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Meuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Talvacchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Knue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayank","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Prodanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoli","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha A.","family":"Zeiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naris","family":"Nilubol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma T.","family":"Shankavaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,18]]},"reference":[{"issue":"2","key":"2857_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/10253890701395896","volume":"10","author":"T Zelinka","year":"2007","unstructured":"T. Zelinka, G. Eisenhofer, K. Pacak, Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice. Stress 10(2), 195\u2013203 (2007)","journal-title":"Stress"},{"issue":"6","key":"2857_CR2","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1210\/jc.2018-01968","volume":"104","author":"S Hescot","year":"2019","unstructured":"S. Hescot et al. Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study. J. Clin. Endocrinol. Metab. 104(6), 2367\u20132374 (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2857_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"L. Fishbein et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31(2), 181\u2013193 (2017)","journal-title":"Cancer Cell"},{"issue":"5","key":"2857_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/ERC-19-0024","volume":"26","author":"J Crona","year":"2019","unstructured":"J. Crona et al. Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis. Endocr. Relat. Cancer 26(5), 539\u2013550 (2019)","journal-title":"Endocr. Relat. Cancer"},{"issue":"17","key":"2857_CR5","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/jnci\/djt201","volume":"105","author":"I Jochmanova","year":"2013","unstructured":"I. Jochmanova et al. Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J. Natl Cancer Inst. 105(17), 1270\u20131283 (2013)","journal-title":"J. Natl Cancer Inst."},{"issue":"34","key":"2857_CR6","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","volume":"23","author":"L Amar","year":"2005","unstructured":"L. Amar et al. Genetic testing in pheochromocytoma or functional paraganglioma. J. Clin. Oncol. 23(34), 8812\u20138818 (2005)","journal-title":"J. Clin. Oncol."},{"issue":"31","key":"2857_CR7","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1200\/JCO.2011.34.6353","volume":"29","author":"KS King","year":"2011","unstructured":"K.S. King et al. Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J. Clin. Oncol. 29(31), 4137\u20134142 (2011)","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"2857_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.surg.2016.05.050","volume":"161","author":"Y Assadipour","year":"2017","unstructured":"Y. Assadipour et al. SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma. Surgery 161(1), 230\u2013239 (2017)","journal-title":"Surgery"},{"key":"2857_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2019.00053","volume":"9","author":"A Jha","year":"2019","unstructured":"A. Jha et al. Clinical, diagnostic, and treatment characteristics of SDHA-related metastatic pheochromocytoma and paraganglioma. Front. Oncol. 9, 53 (2019)","journal-title":"Front. Oncol."},{"issue":"5","key":"2857_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"C. Trapnell et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28(5), 511\u2013515 (2010)","journal-title":"Nat. Biotechnol."},{"issue":"5543","key":"2857_CR11","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.1065329","volume":"294","author":"RC Lee","year":"2001","unstructured":"R.C. Lee, V. Ambros, An extensive class of small RNAs in Caenorhabditis elegans. Science 294(5543), 862\u2013864 (2001)","journal-title":"Science"},{"issue":"2","key":"2857_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281\u2013297 (2004)","journal-title":"Cell"},{"issue":"7","key":"2857_CR13","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1074\/jbc.M114.596866","volume":"290","author":"X Wang","year":"2015","unstructured":"X. Wang et al. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J. Biol. Chem. 290(7), 3925\u20133935 (2015)","journal-title":"J. Biol. Chem."},{"issue":"1","key":"2857_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molcel.2013.08.027","volume":"52","author":"AN Kallen","year":"2013","unstructured":"A.N. Kallen et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell 52(1), 101\u2013112 (2013)","journal-title":"Mol. Cell"},{"key":"2857_CR15","doi-asserted-by":"publisher","unstructured":"G. Adrian et al. MicroRNA signature associated with prognosis and progression in chronic Lymphocytic Leukemia. New England J. Med. 353(17), 1793\u20131801 (2005). https:\/\/doi.org\/10.1056\/NEJMoa050995","DOI":"10.1056\/NEJMoa050995"},{"issue":"14","key":"2857_CR16","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","volume":"65","author":"JA Chan","year":"2015","unstructured":"J.A. Chan, A.M. Krichevsky, K.S. Kosik, MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells. Cancer Res. 65(14), 6029\u20136033 (2015). https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0137","journal-title":"Cancer Res."},{"key":"2857_CR17","doi-asserted-by":"publisher","unstructured":"A. Cimmino et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad. Sci. 102(39), 13944\u201313949 (2005). https:\/\/doi.org\/10.1073\/pnas.0506654102","DOI":"10.1073\/pnas.0506654102"},{"issue":"8","key":"2857_CR18","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1002\/ijc.32654","volume":"146","author":"S Ghosal","year":"2020","unstructured":"S. Ghosal et al. Long intergenic noncoding RNA profiles of pheochromocytoma and paraganglioma: a novel prognostic biomarker. Int. J. Cancer 146(8), 2326\u20132335 (2020)","journal-title":"Int. J. Cancer"},{"key":"2857_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.humpath.2017.03.017","volume":"64","author":"S Pillai","year":"2017","unstructured":"S. Pillai et al. MicroRNA 183 family profiles in pheochromocytomas are related to clinical parameters and SDHB expression. Hum. Pathol. 64, 91\u201397 (2017)","journal-title":"Hum. Pathol."},{"issue":"1","key":"2857_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"M.D. Robinson, D.J. McCarthy, G.K. Smyth, edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1), 139\u2013140 (2010)","journal-title":"Bioinformatics"},{"issue":"15","key":"2857_CR21","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/bioinformatics\/bts344","volume":"28","author":"A Jeggari","year":"2012","unstructured":"A. Jeggari, D.S. Marks, E. Larsson, miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics 28(15), 2062\u20132063 (2012)","journal-title":"Bioinformatics"},{"key":"2857_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep22334","volume":"6","author":"S Ghosal","year":"2016","unstructured":"S. Ghosal et al. miRepress: modelling gene expression regulation by microRNA with non-conventional binding sites. Sci. Rep. 6, 22334 (2016)","journal-title":"Sci. Rep."},{"key":"2857_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7044","volume":"6","author":"LJ Castro-Vega","year":"2015","unstructured":"L.J. Castro-Vega et al. Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas. Nat. Commun. 6, 6044 (2015)","journal-title":"Nat. Commun."},{"issue":"4","key":"2857_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1530\/ERC-12-0183","volume":"20","author":"AA de Cubas","year":"2013","unstructured":"A.A. de Cubas et al. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways. Endocr. Relat. Cancer 20(4), 477\u2013493 (2013)","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"2857_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","volume":"96","author":"M Ayala-Ramirez","year":"2011","unstructured":"M. Ayala-Ramirez et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J. Clin. Endocrinol. Metab. 96(3), 717\u2013725 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"D1","key":"2857_CR26","doi-asserted-by":"publisher","first-page":"D104","DOI":"10.1093\/nar\/gkw888","volume":"45","author":"B Hu","year":"2017","unstructured":"B. Hu et al. POSTAR: a platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins. Nucleic Acids Res. 45(D1), D104\u2013D114 (2017)","journal-title":"Nucleic Acids Res."},{"key":"2857_CR27","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3389\/fgene.2019.01341","volume":"10","author":"YK Zhou","year":"2019","unstructured":"Y.K. Zhou et al. Predicting lncRNA-protein interactions with miRNAs as mediators in a heterogeneous network model. Front. Genet. 10, 1341 (2019)","journal-title":"Front. Genet."},{"issue":"3","key":"2857_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","volume":"57","author":"G Eisenhofer","year":"2011","unstructured":"G. Eisenhofer et al. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin. Chem. 57(3), 411\u2013420 (2011)","journal-title":"Clin. Chem."},{"issue":"1","key":"2857_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1677\/ERC-10-0211","volume":"18","author":"G Eisenhofer","year":"2011","unstructured":"G. Eisenhofer et al. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr.-Relat. Cancer 18(1), 97\u2013111 (2011)","journal-title":"Endocr.-Relat. Cancer"},{"issue":"3","key":"2857_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4158\/EP15725.OR","volume":"22","author":"H Turkova","year":"2016","unstructured":"H. Turkova et al. Characteristics and outcomes of metastatic Sdhb and sporadic pheochromocytoma\/paraganglioma: an National Institutes of Health study. Endocr. Pract. 22(3), 302\u2013314 (2016)","journal-title":"Endocr. Pract."},{"issue":"8","key":"2857_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/jmedgenet-2018-105714","volume":"56","author":"L Ben Aim","year":"2019","unstructured":"L. Ben Aim et al. Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma. J. Med. Genet. 56(8), 513\u2013520 (2019)","journal-title":"J. Med. Genet."},{"issue":"6","key":"2857_CR32","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1530\/ERC-11-0170","volume":"18","author":"J Welander","year":"2011","unstructured":"J. Welander, P. Soderkvist, O. Gimm, Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr.-Relat. Cancer 18(6), R253\u2013R276 (2011)","journal-title":"Endocr.-Relat. Cancer"},{"issue":"11","key":"2857_CR33","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","volume":"48","author":"G Eisenhofer","year":"2012","unstructured":"G. Eisenhofer et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur. J. Cancer 48(11), 1739\u20131749 (2012)","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"2857_CR34","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/1078-0432.CCR-18-0139","volume":"25","author":"S Job","year":"2019","unstructured":"S. Job et al. Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma. Clin. Cancer Res. 25(2), 760\u2013770 (2019)","journal-title":"Clin. Cancer Res."},{"key":"2857_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7140","volume":"6","author":"L Fishbein","year":"2015","unstructured":"L. Fishbein et al. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat. Commun. 6, 6140 (2015)","journal-title":"Nat. Commun."},{"issue":"1","key":"2857_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/ERC-17-0306","volume":"25","author":"T Dwight","year":"2018","unstructured":"T. Dwight et al. TERT structural rearrangements in metastatic pheochromocytomas. Endocr.-Relat. Cancer 25(1), 1\u20139 (2018)","journal-title":"Endocr.-Relat. Cancer"},{"issue":"5","key":"2857_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/cen.13434","volume":"87","author":"O Hamidi","year":"2017","unstructured":"O. Hamidi et al. Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: a systematic review and meta-analysis. Clin. Endocrinol. 87(5), 440\u2013450 (2017)","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"2857_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12020-011-9545-3","volume":"40","author":"TI Korevaar","year":"2011","unstructured":"T.I. Korevaar, A.B. Grossman, Pheochromocytomas and paragangliomas: assessment of malignant potential. Endocrine 40(3), 354\u2013365 (2011)","journal-title":"Endocrine"},{"issue":"2","key":"2857_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1530\/ERC-11-0308","volume":"19","author":"E Patterson","year":"2012","unstructured":"E. Patterson et al. The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma. Endocr.-Relat. Cancer 19(2), 157\u2013166 (2012)","journal-title":"Endocr.-Relat. Cancer"},{"issue":"3","key":"2857_CR40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s10528-017-9793-x","volume":"55","author":"S Azarbarzin","year":"2017","unstructured":"S. Azarbarzin et al. The value of MiR-383, an intronic MiRNA, as a diagnostic and prognostic biomarker in intestinal-type gastric cancer. Biochem. Genet. 55(3), 244\u2013252 (2017)","journal-title":"Biochem. Genet."},{"issue":"8","key":"2857_CR41","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1089\/dna.2019.4624","volume":"38","author":"C Zhu","year":"2019","unstructured":"C. Zhu, Q. Huang, H. Zhu, miR-383 inhibited the cell cycle progression of gastric cancer cells via targeting cyclin E2. DNA Cell. Biol. 38(8), 849\u2013856 (2019)","journal-title":"DNA Cell. Biol."},{"issue":"21","key":"2857_CR42","doi-asserted-by":"publisher","first-page":"10293","DOI":"10.18632\/oncotarget.2511","volume":"5","author":"T Wang","year":"2014","unstructured":"T. Wang et al. CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling. Oncotarget 5(21), 10293\u201310306 (2014)","journal-title":"Oncotarget"},{"issue":"34","key":"2857_CR43","doi-asserted-by":"publisher","first-page":"36522","DOI":"10.18632\/oncotarget.5204","volume":"6","author":"FH Khan","year":"2015","unstructured":"F.H. Khan et al. RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes. Oncotarget 6(34), 36522\u201336534 (2015)","journal-title":"Oncotarget"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02857-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02857-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02857-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T12:28:04Z","timestamp":1642422484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02857-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,18]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2857"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02857-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,18]]},"assertion":[{"value":"10 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}